Vident Investment Advisory’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-12,214
Closed -$311K 1028
2023
Q2
$311K Buy
12,214
+2,289
+23% +$55.5K 0.01% 862
2023
Q1
$221K Buy
+9,925
New +$240K 0.01% 1068
2021
Q3
Sell
-5,400
Closed -$216K 1242
2021
Q2
$216K Buy
+5,400
New +$231K 0.01% 1027

Other funds holding VCYT

Vident Investment Advisory's VCYT Position: Q3 2023 in Review

Vident Investment Advisory sold out of Veracyte (VCYT) in Q3 2023, closing a stake of 12,214 shares — an estimated $311K sold.

Vident Investment Advisory first reported a position in VCYT in Q2 2021 and held it in 3 quarters. The position peaked at $311K in Q2 2023. 236 funds tracked by Wall St. Rank hold VCYT as of Q3 2023.

  • Vident Investment Advisory reported no remaining Veracyte position as of Q3 2023 after selling out during the quarter.
  • Vident Investment Advisory sold 12,214 Veracyte shares in Q3 2023, an estimated $311K.
  • Vident Investment Advisory first reported a position in Veracyte in Q2 2021 and held it in 3 quarters.
  • Vident Investment Advisory's Veracyte position peaked at $311K in Q2 2023.
  • 236 funds tracked by Wall St. Rank held Veracyte as of Q3 2023.

Based on Vident Investment Advisory's 13F filing for Q3 2023.